Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant)

Annals of Hematology

Volumn 89, Issue 2, 2010, Pages 217-219

  Sobas, Marta Anna ^a   Vence, Natalia Alonso ^a   Arias, Jose Diaz ^a   Lopez, Angeles Bendaña ^a   Rodriguez, Maximo Fraga ^a   Lopez, Jose Luis Bello ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; PREDNISONE; RITUXIMAB; STEROID; BORONIC ACID DERIVATIVE; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANOREXIA; ASCITES; ASTHENIA; BONE MARROW BIOPSY; BONE RADIOGRAPHY; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DYSESTHESIA; ESOPHAGUS VARICES BLEEDING; GENERALIZED EDEMA; HUMAN; HUMAN TISSUE; LETTER; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PLEURA EFFUSION; POEMS SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL; RASH; REMISSION; REPEATED DRUG DOSE; SPLENOMEGALY; STEROID THERAPY; THORACOCENTESIS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

BORONIC ACIDS; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED; POEMS SYNDROME; PROTEASE INHIBITORS; PYRAZINES; TREATMENT OUTCOME;

EID: 74049107864     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0795-6     Document Type: Letter

References (10)

1. Castleman B, Iverson L, Mendez VP (1956) Localizad mediastinal lymph node hyperplasia resembling thymoma. Cancer 9:822-830.
2. Casper C (2005) The aetiology and management of Castelman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129:3-17.
3. Hess G, Wagner V, Kreft A, Heussel CP, Huber Ch (2006) Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castelman disease. Br J Haematol 134:544-549.
4. Dispenzieri A (2007) POEMS syndrome. Blood Rev 21:285-299.
5. Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, Castilla C, Blanco OJ, Caballero D, San Miguel J (2005) Efficacy of Rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol 78:302-305.
6. Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Ankara H, Hagihara K, Yoshizaki K, Kishimoto T (2005) Humanized anti-interleukin-6 receptor antibody tratment of multicentric Castelman disease. Blood 106:2627-2632.
7. Beck JT, Hsu SM, Wijdenes J et al (1994) Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330:602-605.
8. Casper C, Nichols WG, Huang ML, Corey L, Wald A (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103:1632-1634.
9. Berezne A, Agbalika F, Oksenhendler E (2004) Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood 103:4368-4369.
10. Hogan WJ, Lacy MQ, Wiseman GA, Fealey RD, Dispenzieri A, Gertz MA (2001) Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 28(3):305-309.